Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Akebia Therapeutics
Biotech
Akebia says FDA staffing issues are delaying appeal process
Akebia says regulators' review of a formal rejection appeal is being delayed due to staffing constraints.
Max Bayer
Feb 21, 2023 10:45am
Akebia is taking the fight to the FDA months after rejection
Nov 4, 2022 12:02pm
Akebia's anemia drug just misses in a COVID-19 trial
Aug 5, 2022 10:14am
After dispute, Otsuka pays Akebia $55M to exit anemia pill pacts
Jul 1, 2022 8:15am
Fierce Biotech launches layoff tracker—Chutes and Ladders
Apr 8, 2022 9:30am
Vifor buys priority review voucher for vadadustat filing
Feb 18, 2020 8:12am